L-glutamine protects against enterohemorrhagic Escherichia coli infection by inhibiting bacterial virulence and enhancing host defense concurrently
Microbiology Spectrum · 12.12.2023 · 11 (6)
DOI: 10.1128/spectrum.00975-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 12.12.2023. Verfasst von Fang Fang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Xiamen Key Laboratory of Perinatal-Neonatal Infection, Women and Children's Hospital, State Key Laboratory of Vacc…. Hauptthemen laut MEDLINE: Escherichia coli Proteins, Escherichia coli Infections, Enterohemorrhagic Escherichia coli, Intestinal Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Shenzhen Municipal Science and Technology Innovation Council | Shenzhen Science and Technology Innovation Program (), China Scholarship Council (CSC).
Abstract (Originalsprache)
Enterohemorrhagic Escherichia coli (EHEC) can colonize the gastrointestinal tract and cause bloody diarrhea in children. Previous studies showed that its pathogenesis could be mediated by metabolites from both the host and microbiota. L-Glutamine (Gln) was found to be depleted in intestinal tissues as the main energy source according to previous studies. Hence, we aimed to determine the effects of Gln on EHEC infection and its underlying mode of action. In this study, a Gln-limited signal was found to activate the type 3 secretion system (T3SS), which is crucial for EHEC infection via perturbation of central metabolism. By shifting the phosphorylation of NtrC, a key regulator in bacterial nitrogen metabolism, Gln stimulates ler transcripts in a σ S -PchA-dependent manner. Our in vivo experiments further demonstrated that Gln supplementation can reduce EHEC colonization in the gastrointestinal tract by repressing T3SS. Moreover, Gln could further attenuate bacterial infection by boosting host defense, which might be dependent on multiple pathways. Besides, our experiments demonstrated that Gln did not induce Shiga-like toxin (Stx) production or cause impairment of gut flora. In conclusion, our study presented evidence that Gln could act against EHEC infection by reducing bacterial virulence and strengthening host defense. Therefore, Gln serves as a promising therapeutic agent for EHEC infection. IMPORTANCE The type 3 secretion system (T3SS) was obtained in many Gram-negative bacterial pathogens, and it is crucial for their pathogenesis. Environmental signals were found to be involved in the expression regulation of T3SS, which was vital for successful bacterial infection in the host. Here, we discovered that L-glutamine (Gln), the most abundant amino acid in the human body, could repress enterohemorrhagic Escherichia coli (EHEC) T3SS expression via nitrogen metabolism and therefore had potential as an antivirulence agent. Our in vitro and in vivo evidence demonstrated that Gln could decline EHEC infection by attenuating bacterial virulence and enhancing host defense simultaneously. We repurpose Gln as a potential treatment for EHEC infection accordingly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Xiamen Key Laboratory of Perinatal-Neonatal Infection, Women and Children's Hospital, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedical Laboratory, School o…
- State Key Laboratory of Infectious Disease Prevention and Control and National Institute for Communicable Diseases Control and Prevention, Chinese Center for Disease Control and Prevention , Changping, Beijing, China.
- Department of Pathology, Women and Children's Hospital, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, Xiame…
- Department of Nephrology, Lishan Hospital, Anshan Central Hospital , Anshan, Liaoning Province, China.
- BiomEdit , Fishers, Indiana, USA.
ORCID-Profile: Xuefang Xu, Dai Wang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Shenzhen Municipal Science and Technology Innovation Council | Shenzhen Science and Technology Innovation Program ()
- China Scholarship Council (CSC)
- | Natural Science Foundation of Fujian Province (Fujian Natural Science Foundation)
- 福建省科技厅 | Natural Science Foundation of Fujian Province
Zitieren
APA
Fang, F., Xue, Y., Xu, X., Fang, D., Liu, W., Zhong, Y., Han, J., Li, Y., Tao, Q., Lu, R., Ma, C., Kumar, A., & Wang, D. (2023). L-glutamine protects against enterohemorrhagic Escherichia coli infection by inhibiting bacterial virulence and enhancing host defense concurrently. Microbiology Spectrum, 11(6). https://doi.org/10.1128/spectrum.00975-23
Vancouver
Fang F, Xue Y, Xu X, Fang D, Liu W, Zhong Y, et al. L-glutamine protects against enterohemorrhagic Escherichia coli infection by inhibiting bacterial virulence and enhancing host defense concurrently. Microbiology Spectrum. 2023;11(6). doi:10.1128/spectrum.00975-23
BibTeX
@article{Fang2023,
author = {Fang, Fang and Xue, Yunxin and Xu, Xuefang and Fang, Dingli and Liu, Weijia and Zhong, Ying and Han, Jinping and Li, Yunhe and Tao, Qian and Lu, Rong and Ma, Cong and Kumar, Arvind and Wang, Dai},
title = {L-glutamine protects against enterohemorrhagic Escherichia coli infection by inhibiting bacterial virulence and enhancing host defense concurrently},
journal = {Microbiology Spectrum},
year = {2023},
volume = {11},
number = {6},
doi = {10.1128/spectrum.00975-23}
}
EUVIMED